Richmond, VA, United States of America

Cesar Ivan Sertzen

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Cesar Ivan Sertzen

Introduction

Cesar Ivan Sertzen is an accomplished inventor based in Richmond, VA. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent that enhances the stability of novel liquid compositions. His work is vital in improving the efficacy and safety of pharmaceutical agents.

Latest Patents

Cesar Ivan Sertzen holds a patent for "Enhanced stability of novel liquid compositions." This invention relates to compositions of pharmaceutical agents combined with additional agents in a mixture of polyethylene glycol, polyvinylpyrrolidone, and propylene glycol. The process of making these compositions is also a key aspect of his patent, which aims to improve the stability and effectiveness of pharmaceutical formulations.

Career Highlights

Cesar is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development projects that aim to bring innovative solutions to the healthcare industry. His expertise in pharmaceutical compositions has positioned him as a valuable asset to the company.

Collaborations

Throughout his career, Cesar has collaborated with notable colleagues, including Gary Robert Agisim and Robert Alan Friedline. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their collective research efforts.

Conclusion

Cesar Ivan Sertzen's contributions to the field of pharmaceuticals through his innovative patent and work at Pfizer Corporation highlight his dedication to improving healthcare solutions. His ongoing efforts in research and development continue to pave the way for advancements in pharmaceutical compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…